Brief: Seoul Pharma signs contract worth 8.62 bln won
27/10/2017 06:20
Oct 27(Reuters) - Seoul Pharma Co Ltd 018680.KQ :
* Says it signed 8.62 billion won contract, to provide ODF
Source text in Korean: https://goo.gl/59Qq5a
Further company coverage: 018680.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: Yinglan.Ma.reuters.com@reuters.net))
Recent news on Seoul Pharma
See all newsBrief: Seoul Pharma Says Terminates Contract Worth $5.3 Million To Supply Erectile Dysfunction Drugs In Middle East Region
Brief: Seoul Pharma appoints CEO
Brief: Seoul Pharma issues 3rd tranche convertible bonds worth 6 bln won
Brief: Seoul Pharma signs contract worth 7.86 bln won
Brief: Seoul Pharma signs contract worth 8.62 bln won